STEVEN M PAUL
CIK 1237564 · CSO and President of R&D · last filed 2026-06-10
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$51.92M
Companies
8
Total Filings
102
Lifetime Open-Market Net
-$76.46M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RAPP | Director | 28,284 | $38.40 | $1.09M | $1.03M | 3 | 2026-06-10 |
| SPTX | Director | 863,031 | — | — | $0 | 1 | 2026-05-04 |
| Karuna Therapeutics, Inc. (KRTX) Delisted | CSO and President of R&D | 0 | $329.83 | $0 | -$29.76M | 12 | 2024-03-18 |
| Sage Therapeutics, Inc. (SAGE) Delisted | Director | 303,377 | $8.68 | $2.63M | -$37.05M | 29 | 2024-01-04 |
| ALNY | Director | 10,799 | $282.85 | $3.05M | -$8.47M | 16 | 2022-04-05 |
| VYGR | Chief Executive Officer | 872,351 | $3.50 | $3.05M | $140.7K | 7 | 2021-06-04 |
| SIGMA ALDRICH CORP (SIAL) Delisted | Director | 0 | — | — | $0 | 19 | 2015-11-19 |
| LLY | EVP, Science and Technology | 39,476 | $1133.00 | $44.73M | -$2.35M | 15 | 2010-02-03 |
Recent Filings · Page 4 of 11
102 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-07-02 | ALNY | Grant (A) | — | $0 | EDGAR |
| 2019-07-02 | Karuna Therapeutics, Inc. (KRTX) Delisted | Conv (C) | +96,485 | $0 | EDGAR |
| 2019-07-01 | Karuna Therapeutics, Inc. (KRTX) Delisted | Mixed | +10,000 | $230.4K | EDGAR |
| 2019-06-17 | VYGR | Grant (A) | — | $0 | EDGAR |
| 2019-06-06 | Sage Therapeutics, Inc. (SAGE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-03-22 | Sage Therapeutics, Inc. (SAGE) Delisted | Sell (S) | −7,879 | -$1.27M | EDGAR |
| 2019-03-20 | Sage Therapeutics, Inc. (SAGE) Delisted | Sell (S) | −60,421 | -$9.74M | EDGAR |
| 2019-03-05 | Sage Therapeutics, Inc. (SAGE) Delisted | Sell (S) | −2,600 | -$418.6K | EDGAR |
| 2019-02-27 | Sage Therapeutics, Inc. (SAGE) Delisted | Mixed | −2,000 | -$322.0K | EDGAR |
| 2019-02-20 | Sage Therapeutics, Inc. (SAGE) Delisted | Mixed | −51,004 | -$8.21M | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.